15-31050541-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001252024.2(TRPM1):​c.1305G>A​(p.Thr435Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.55 in 1,613,692 control chromosomes in the GnomAD database, including 252,022 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.48 ( 19500 hom., cov: 31)
Exomes 𝑓: 0.56 ( 232522 hom. )

Consequence

TRPM1
NM_001252024.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.87

Publications

25 publications found
Variant links:
Genes affected
TRPM1 (HGNC:7146): (transient receptor potential cation channel subfamily M member 1) This gene encodes a member of the transient receptor potential melastatin subfamily of transient receptor potential ion channels. The encoded protein is a calcium permeable cation channel that is expressed in melanocytes and may play a role in melanin synthesis. Specific mutations in this gene are the cause autosomal recessive complete congenital stationary night blindness-1C. The expression of this protein is inversely correlated with melanoma aggressiveness and as such it is used as a prognostic marker for melanoma metastasis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
TRPM1 Gene-Disease associations (from GenCC):
  • congenital stationary night blindness 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • TRPM1-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 15-31050541-C-T is Benign according to our data. Variant chr15-31050541-C-T is described in ClinVar as Benign. ClinVar VariationId is 193856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.87 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.919 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRPM1NM_001252024.2 linkc.1305G>A p.Thr435Thr synonymous_variant Exon 12 of 28 ENST00000256552.11 NP_001238953.1
TRPM1NM_001252020.2 linkc.1356G>A p.Thr452Thr synonymous_variant Exon 11 of 27 NP_001238949.1
TRPM1NM_002420.6 linkc.1239G>A p.Thr413Thr synonymous_variant Exon 11 of 27 NP_002411.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRPM1ENST00000256552.11 linkc.1305G>A p.Thr435Thr synonymous_variant Exon 12 of 28 1 NM_001252024.2 ENSP00000256552.7

Frequencies

GnomAD3 genomes
AF:
0.480
AC:
72871
AN:
151764
Hom.:
19503
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.235
Gnomad AMI
AF:
0.407
Gnomad AMR
AF:
0.574
Gnomad ASJ
AF:
0.566
Gnomad EAS
AF:
0.941
Gnomad SAS
AF:
0.506
Gnomad FIN
AF:
0.542
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.558
Gnomad OTH
AF:
0.505
GnomAD2 exomes
AF:
0.555
AC:
136961
AN:
246920
AF XY:
0.550
show subpopulations
Gnomad AFR exome
AF:
0.227
Gnomad AMR exome
AF:
0.600
Gnomad ASJ exome
AF:
0.559
Gnomad EAS exome
AF:
0.963
Gnomad FIN exome
AF:
0.541
Gnomad NFE exome
AF:
0.546
Gnomad OTH exome
AF:
0.561
GnomAD4 exome
AF:
0.558
AC:
815022
AN:
1461810
Hom.:
232522
Cov.:
70
AF XY:
0.556
AC XY:
404090
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.214
AC:
7181
AN:
33480
American (AMR)
AF:
0.599
AC:
26778
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.562
AC:
14700
AN:
26136
East Asian (EAS)
AF:
0.909
AC:
36095
AN:
39696
South Asian (SAS)
AF:
0.478
AC:
41213
AN:
86258
European-Finnish (FIN)
AF:
0.540
AC:
28815
AN:
53398
Middle Eastern (MID)
AF:
0.463
AC:
2673
AN:
5768
European-Non Finnish (NFE)
AF:
0.561
AC:
623961
AN:
1111974
Other (OTH)
AF:
0.556
AC:
33606
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
22569
45138
67707
90276
112845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17444
34888
52332
69776
87220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.480
AC:
72893
AN:
151882
Hom.:
19500
Cov.:
31
AF XY:
0.483
AC XY:
35854
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.235
AC:
9716
AN:
41418
American (AMR)
AF:
0.574
AC:
8762
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.566
AC:
1962
AN:
3468
East Asian (EAS)
AF:
0.941
AC:
4850
AN:
5156
South Asian (SAS)
AF:
0.505
AC:
2423
AN:
4794
European-Finnish (FIN)
AF:
0.542
AC:
5720
AN:
10548
Middle Eastern (MID)
AF:
0.500
AC:
145
AN:
290
European-Non Finnish (NFE)
AF:
0.558
AC:
37882
AN:
67926
Other (OTH)
AF:
0.505
AC:
1063
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1712
3424
5136
6848
8560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.527
Hom.:
39871
Bravo
AF:
0.474
Asia WGS
AF:
0.653
AC:
2267
AN:
3478
EpiCase
AF:
0.552
EpiControl
AF:
0.543

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital stationary night blindness 1C Benign:2
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
Mar 11, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.3
DANN
Benign
0.63
PhyloP100
-1.9
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1035705; hg19: chr15-31342744; COSMIC: COSV56632216; API